Amo Groningen B.v.

Advanced Medical Optics, Inc.

Sieger Meijer

Carmen Canovas Vidal

Robert Rosen

Aixa Alarcon Heredia

Mihai State

Hendrik Albert Weeber

Marrie H Van Der Mooren

Luuk Franssen

Kaccie Y Li

Richard Hartman

Robin Zonneveld

Theophilus Bogaert

Bram Koopman

Theo T M Bogaert

Bart Cannegieter

Robert ROSÉN

Intraocular lenses for reducing negative dysphotpsia (ND) are described herein. An example ophthalmic lens can include an optic () with a central optical zone () disposed about the optical axis (OA) and an attenuation optical zone () disposed about the central optical zone (), wherein the attenuation optical zone () is contiguous with the central optical zone (), and wherein optical power of the ophthalmic lens is gradually reduced within the attenuation optical zone ().

Intraocular lenses for reducing negative dysphotopsia

Systems and methods for evaluating ND are described herein. An example method can include constructing a non-sequential (NSC) ray-tracing model of an eye with an ophthalmic lens, and modelling a light source and a detector. The detector can be configured to mimic a retina of the eye. The method can also include computing irradiance data using the light source, the NSC ray-tracing model, and the detector. Irradiance data can be computed for each of a plurality of pupil sizes. The method can further include evaluating ND by analyzing the respective irradiance data for each of the pupil sizes. Also described herein are methods for designing an ophthalmic lens edge that reduces the incidence of ND for a given ophthalmic lens by adjusting the edge thickness and/or the scatter.

Systems and methods for evaluating and reducing negative dysphotopsia

Intraocular lenses for reducing the risk of posterior capsule opacification (PCO) are described herein. PCO can be reduced with an IOL design that increases the pressure at the posterior capsular bend, for example, by including a sharper edge design, an enlarged optical zone, and/or an increased vault height. An example ophthalmic lens can include an optic () including an anterior surface () defining an anterior side of the optic, a posterior surface () defining a posterior side of the optic, and an edge () arranged between the anterior and posterior surfaces. The edge and the posterior surface can form an angle, where the angle is less than about 90 degrees. Additionally, the ophthalmic lens can have an increased vault height. At least one of the angle or the increased vault height be configured to increase pressure on a capsular bend in a subject's eye.

Intraocular lenses for reducing the risk of posterior capsule opacification

An apparatus, system and method for constricting a cornea of a human eye are disclosed. A control device external to the subject eye, such as an induction generator, may be configured to create a stimulus, such as a magnetic field, for an implanted ring that, when stimulated, may change the curvature, and thus the dioptric power, of the eye, thereby approximating natural accommodation.

Apparatus, system, and method for providing an implantable ring for altering a shape of the cornea

The present invention relates to an intraocular correction lens for implantation in the posterior chamber of the eye between the iris and the intact natural lens. The lens has a concave posterior surface which is part of a non-spherical surface that is rotation symmetric around the optical axis of said optical part, wherein the intersection between said non-spherical surface and any plane containing the optical axis of the lens represents a flawless curve free from discontinuities and points of inflection. The invention also relates to methods of selecting correction lenses based on estimations of the individual eye in need of vision correction and thereby arriving with a correction lens with a high safety for wearer with respect to surrounding eye tissues.

Intraocular lenses

Growing community of inventors

Zuidlaren, Netherlands

Sieger Meijer